Skip to content

ColoAssist vs. MEI

ColoAssist vs. Magnetic Guided Colonoscopy - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01895504
Enrollment
475
Registered
2013-07-10
Start date
2013-04-30
Completion date
2014-07-31
Last updated
2015-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Screening

Keywords

Colonoscopy, Colorectal cancer, Adenoma

Brief summary

Colonoscopy aims to investigate the entire colon by advancing the colonoscope tip from the rectum to the cecum, a process called cecal intubation. Cecal intubation may be difficult for different reasons, and features of the colonoscope and the use of imaging devices may influence the success rate. We want to compare the performance of a new colonoscope with novel features including gradual stiffness with that of a colonoscope supplied with a magnetic endoscope imaging (MEI) device. The hypothesis is that the performance of the new instrument is non-inferior to the MEI system.

Detailed description

The recommended cecal intubation rate in colorectal cancer (CRC) screening is 95%. The MEI system allows real time monitoring of the colonoscope position within the colon and is considered to be a useful supplement to achieve cecal intubation. However, the MEI system is costly, and trial results are equivocal regarding the actual benefits. A newly designed colonoscope (ColoAssist) with gradual stiffness throughout the colonoscope shaft has been developed to improve insertability. We want to investigate if we can achieve equal performance results with the ColoAssist instrument as with the MEI system in CRC screening. The study is designed as a two-center, single-blinded, randomized, controlled non-inferiority trial.

Interventions

DEVICEColoAssist

Screening colonoscopy with the test instrument

DEVICEMEI

Colonoscopy with Olympus colonoscopes and MEI guidance

Sponsors

Sorlandet Hospital HF
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
55 Years to 66 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion in an ongoing colorectal cancer screening trial (NCT 00883792)

Exclusion criteria

* Excluded from the ongoing screening trial (NCT 00883792) * Inability or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Cecal intubation rate1 hourThe ability to reach the cecum during colonoscopy

Secondary

MeasureTime frameDescription
Cecal intubation time1 hourTime to reach the cecum during colonoscopy
Adenoma detection rate1 hourThe proportion of participants in whom at least one adenoma is detected
Polyp detection rate1 hourThe proportion of participants in whom at least one polyp i detected
Pain24 hoursParticipants will be asked to score discomfort or pain during and after colonoscopy

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026